Major Editorials, Commentaries, and Reviews by DCEG Scientists

• Blair A, Marrett L, Beane Freeman L. Occupational cancer in developed countries. Environ Health 2011;10(Suppl. 1):S9
• Biankin AV, Chanock SJ. The road ahead: Less travelled and more arduous than initially envisioned. Hum Genet 2011;130:1–2
• Chung CC, Chanock SJ. Current status of genome-wide association studies in cancer. Hum Genet 2011;130:59–78
• Cook MB, Trabert B, McGlynn KA. Organochlorine compounds and testicular dysgenesis syndrome: Human data. Int J Androl 2011;34(4 Pt 2):e68–e85
• Daugherty SE, Pfeiffer RM, Sigurdson AJ, et al. Nonsteroidal antiinflammatory drugs and bladder cancer: A pooled analysis. Am J Epidemiol 2011;173:721–730
• Gail MH. Personalized estimates of breast cancer risk in clinical practice and public health. Stat Med 2011;30:1090–1104
• Ghosh A, Castle PE. Invited commentary: The importance of prevalence in the effectiveness of a (bio)marker. Am J Epidemiol 2011;173:1388–1390
• Hosgood HD III, Wei H, Sapkota A, Choudhury I, Bruce N, Smith KR, Rothman N, Lan Q. Household coal use and lung cancer: Systematic review and meta-analysis of case-control studies, with an emphasis on geographic variation. Int J Epidemiol 11;40:719–728
• Kitahara CM. Low-glycemic load diets: How does the evidence for prevention of disease measure up? J Am Diet Assoc 2010;110:1818–1819
• Kratz CP, Rapisuwon S, Reed H, et al. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes. Am J Med Genet C Semin Med Genet 2011;157:83–89
• Kreimer AR, Chaturvedi AK. HPV-associated oropharyngeal cancers—Are they preventable? Cancer Prev Res (Phila) 2011;4:1346–1349
• McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: Present and future. Clin Liver Dis 2011;15:223–243, vii–x
• Morton LM, Chanock SJ. A step toward slaying the hydra of second cancers. Nat Med 2011;17:924–925
• Rosenberg PS, Anderson WF. Age-period-cohort models in cancer surveillance research: Ready for prime time? Cancer Epidemiol Biomarkers Prev 2011;20:1263–1268
• Sampson JN. What are the consequences if I postpone treatment of my PSA-detected prostate cancer? Cancer Epidemiol Biomarkers Prev 2011;20:727–728
• Freedman LS, Schatzkin A, et al. Dealing with dietary measurement error in nutritional cohort studies. J Natl Cancer Inst 2011;103:1086–1092
• Schonfeld SJ, Lee C, Berrington de González A. Medical exposure to radiation and thyroid cancer. Clin Oncol (R Coll Radiol) 2011;23:244–250
• Coleman CN, Simon SL, et al. Disaster preparation: Lessons from Japan. Science 2011;332:1379
• Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA. The association of telomere length and cancer: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2011;20:1238–1250